Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Alethia Biotherapeutics (Canada), a preclinical-stage biotechnology company focused on bone degredation, closed a $4.7M Series B financing. Participants include AgeChem Venture Fund, BDC Venture Capital and GO Capital. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive Collective IP Account […]

Dekkun (Cambridge, MA) a development-stage bioscience company focused on treatments of bone fractures and oncology. Participants include HealthCare Ventures.

Graftys (France) a commercial-stage medical device company focused on minimally invasive femoroplasty using bisphosphonateloaded synthetic bone substitute to prevent contralateral hip fracture after osteoporotic fracture, closed a $5.3M Series C financing. Participants include Ventech, Octalfa, Oreo Finances and Viveris Management.

  

to top of page...